Alopecia in Patients with COVID-19: A Systematic Review and Meta-Analysis

    February 2022 in “ JAAD International ”
    Betty Nguyen, Antonella Tosti
    Studysummary This review analyzed data on alopecia types associated with COVID-19, suggesting androgenetic alopecia may be a risk factor for severe COVID-19, while telogen effluvium often follows infection and alopecia areata tends to relapse in those with preexisting disease.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on jaadinternational.org →
    Discuss this study in the Community →

    Research cited in this study 43

    1. COVID-19 Infection Is a Major Cause of Acute Telogen Effluvium Irish Journal of Medical Science (1971 -) · 2021
    2. Time of Onset and Duration of Post-COVID-19 Acute Telogen Effluvium Journal of The American Academy of Dermatology · 2021
    3. Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled Trial Frontiers in Medicine · 2021
    4. Mild-To-Moderate COVID-19 Is Not Associated With Worsening Of Alopecia Areata: A Retrospective Analysis Of 32 Patients Journal of The American Academy of Dermatology · 2021
    5. Androgenetic Alopecia and COVID-19: A Review of the Hypothetical Role of Androgens Dermatologic Therapy · 2021
    6. Androgenetic Alopecia in Women and Men Is Not Related to COVID-19 Infection Severity: A Prospective Cohort Study of Hospitalized COVID-19 Patients Journal of The European Academy of Dermatology and Venereology · 2021
    7. Clinical Course of Alopecia After COVID-19 International Journal of Infectious Diseases · 2021
    8. COVID-19 Dermatological Manifestations: Results from the Mexican Academy of Dermatology COVID-19 Registry International Journal of Dermatology · 2021
    9. Pathobiology Questions Raised by Telogen Effluvium and Trichodynia in COVID-19 Patients Experimental Dermatology · 2021
    10. A Case of Acute Telogen Effluvium After SARS-CoV-2 Infection Clinical, Cosmetic and Investigational Dermatology · 2021
    11. New Onset of Alopecia Areata in a Patient with SARS-CoV-2 Infection: Possible Pathogenetic Correlations Journal of cosmetic dermatology (Print) · 2021
    12. Clinical Characteristics And Outcomes Of Adult Patients Admitted With COVID-19 In East London: A Retrospective Cohort Analysis BMJ Open Respiratory Research · 2021
    13. Alopecia and Severity of COVID-19: A Cross-Sectional Study in Peru Le infezioni in medicina · 2021
    14. Hair Loss as a Late Complication of Multisystem Inflammatory Syndrome in Children The Pediatric Infectious Disease Journal · 2021
    15. Proxalutamide Significantly Accelerates Viral Clearance and Reduces Time to Clinical Remission in Patients with Mild to Moderate COVID-19: Results from a Randomized, Double-Blinded, Placebo-Controlled Trial Cureus · 2021
    16. Rapidly Progressive Alopecia Areata Totalis in a COVID-19 Patient, Unresponsive to Tofacitinib Journal of the European Academy of Dermatology and Venereology · 2021
    17. Italian Survey for the Evaluation of the Effects of Coronavirus Disease 2019 Pandemic on Alopecia Areata Recurrence Dermatology and Therapy · 2021
    18. Telogen Effluvium Associated with COVID-19 Infection Dermatologic Therapy · 2021
    19. Patient Recovery from COVID-19 Infections: Follow-Up of Hair, Nail, and Skin Manifestations BioMed Research International · 2021
    20. Telogen Effluvium After SARS-CoV-2 Infection: A Series of Cases and Possible Pathogenetic Mechanisms Skin appendage disorders · 2021
    21. Anti-Androgens May Protect Against Severe COVID-19 Outcomes: Results From a Prospective Cohort Study of 77 Hospitalized Men Journal of The European Academy of Dermatology and Venereology · 2021
    22. What Can Hair Tell Us About COVID-19? Experimental Dermatology · 2020
    23. Telogen Effluvium: A Sequela of COVID-19 International Journal of Dermatology · 2020
    24. SARS-CoV-2-Induced Telogen Effluvium: A Multicentric Study Journal of the European Academy of Dermatology and Venereology · 2020
    25. Telogen Effluvium Related to Post Severe SARS-CoV-2 Infection: Clinical Aspects and Our Management Experience Dermatologic Therapy · 2020
    26. Sex Differences in COVID-19: The Role of Androgens in Disease Severity and Progression Endocrine · 2020
    27. The Impact of Individual Lifestyle and Status on the Acquisition of COVID-19: A Case-Control Study PLOS ONE · 2020
    28. Alopecia and Grey Hair Are Associated with COVID-19 Severity Experimental Dermatology · 2020
    29. Prolonged and Late-Onset Symptoms of Coronavirus Disease 2019 Open Forum Infectious Diseases · 2020
    30. The Role of Androgens in COVID-19 Diabetes and Metabolic Syndrome: Clinical Research and Reviews · 2020
    31. Sex Hormones and Hormone Therapy during COVID-19 Pandemic: Implications for Patients with Cancer Cancers · 2020
    32. Male Balding Is a Major Risk Factor for Severe COVID-19 Journal of The American Academy of Dermatology · 2020
    33. Cutaneous Manifestations and Considerations in COVID-19 Pandemic: A Systematic Review Dermatologic therapy · 2020
    34. Androgenetic Alopecia Present in the Majority of Patients Hospitalized with COVID-19: The 'Gabrin Sign' Journal of The American Academy of Dermatology · 2020
    35. Covid-19 And Dermatology: A Comprehensive Guide For Dermatologists Journal of the European Academy of Dermatology and Venereology · 2020
    36. Cutaneous Signs in COVID-19 Patients: A Review Dermatologic Therapy · 2020
    37. A Preliminary Observation: Male Pattern Hair Loss Among Hospitalized COVID-19 Patients in Spain – A Potential Clue to the Role of Androgens in COVID-19 Severity Journal of Cosmetic Dermatology · 2020
    38. Alopecia Areata: A Review of Disease Pathogenesis British journal of dermatology/British journal of dermatology, Supplement · 2018
    39. Evaluation of the Relationship Between Alopecia Areata and Viral Antigen Exposure American journal of clinical dermatology · 2017
    40. Telogen Effluvium: A Review Journal of Clinical and Diagnostic Research · 2015
    41. Androgenetic Alopecia in Men Aged 40-69 Years: Prevalence and Risk Factors British Journal of Dermatology · 2003
    42. Hair Density, Hair Diameter, and the Prevalence of Female Pattern Hair Loss British Journal of Dermatology · 2001
    43. Diffuse Hair Loss: Causes, Diagnosis, and Treatment International Journal of Dermatology · 1999

    Related research 3

    1. Alopecia Areata: A Multifactorial Autoimmune Condition Journal of autoimmunity · 2018
    2. Linear Alopecia Areata JAAD case reports · 2018
    3. Treating Resistant Cases of Alopecia Universalis Journal of cosmetology & trichology · 2018